Biotech

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

2024-05-18 05:46 1450

Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world's largest pre-college science, technology, engineering and math (STEM) competition. TARRYTOWN, N.Y. and WASHINGTON, May 18, 2024 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: RE...

GV Announces Cooperation with Top 500 Company in China

2024-05-17 20:30 1391

TORONTO, May 17, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company and Red Sun...

LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care

2024-05-17 18:33 2566

HANOI, Vietnam, May 17, 2024 /PRNewswire/ -- LiveSpo Pharma is the first Vietnamese entity to report on clinical studies at Vitafoods Europe 2024, held inGeneva, Switzerland. LiveSpo Pharma showcased its range of high-concentration, multi-strain liquid medical probiotics products, affirming the ...

Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference

2024-05-17 12:01 972

* Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals ofZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab * The data underscores Celltrion's commitment to improving patient outcomes and advancing scientific understanding in th...

Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality

2024-05-17 07:00 4549

Australian animal health leader adopts Veeva Vault QualityDocs and Veeva Vault Training for greater efficiency and compliance SYDNEY, May 17, 2024 /PRNewswire/ -- Troy Animal Healthcare and Veeva Systems  (NYSE: VEEV) today announced Troy's selection of Veeva Vaul...

Visionary Has World-Class Biochip Technology Products

2024-05-16 20:30 1493

TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company has coopera...

EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress

2024-05-16 09:03 1110

SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...

Origin Agritech Reports Strong Financial Results for the First Half of FY2024 and Highlights Significant Advancements in GMO Corn Approval

2024-05-15 19:30 2195

BEIJING, May 15, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced its unaudited financial results for the six months endedMarch 31, 2024. The Company also provided updates on its key product de...

HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols

2024-05-14 20:00 1130

PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...

Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions

2024-05-14 11:24 1706

SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...

Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies

2024-05-14 07:27 1326

DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today announced tha...

BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000

2024-05-13 13:34 1486

SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...

SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers

2024-05-13 10:00 2788

SINGAPORE, May 13, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor-...

Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention

2024-05-11 15:14 2958

NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention onWednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in Com...

Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)

2024-05-10 20:07 1953

SHENZHEN, China, May 10, 2024 /PRNewswire/ -- On the evening of May 5, Kexing Biopharm (stock code: 688136) announced it had obtained a "Certificate of GMP Compliance of a Manufacturer" granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency (EMA) regulat...

Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides

2024-05-10 18:39 1884

* FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing o...

RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge Sharing

2024-05-10 16:26 1905

The biotech company continues to offer hope to systemic lupus erythematosus ( SLE) patients globally by sharing the latest developments of its proprietary novel fusion protein drug Telitacicept YANTAI, China, May 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd.  ("RemeGen" or "t...

WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval

2024-05-10 12:16 1576

CHENGDU, China, May 10, 2024 /PRNewswire/ -- WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA ...

SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer

2024-05-10 12:00 1222

SEOUL, South Korea, May 9, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101 ...

Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition cost

2024-05-10 07:41 972

* Adalimumab-aaty will be priced at an 85% discount to HUMIRA® (adalimumab) * Branded and unbranded versions of Celltrion USA's adalimumab biosimilar help provide more affordable options for patients JERSEY CITY, N.J., May 9, 2024 /PRNewswire/ -- CelltrionUSA announced today that adalimumab-aa...

12345 ... 150